154 related articles for article (PubMed ID: 7462771)
1. Platelet changes after placement of aortic prostheses in dogs. II. Impaired surface-induced arterial thrombosis.
Clagett GP; Russo M; Hufnagel H
J Lab Clin Med; 1981 Mar; 97(3):360-8. PubMed ID: 7462771
[TBL] [Abstract][Full Text] [Related]
2. Platelet changes after placement of aortic prostheses in dogs. I. Biochemical and functional alterations.
Clagett GP; Russo M; Hufnagel H
J Lab Clin Med; 1981 Mar; 97(3):345-59. PubMed ID: 6161974
[TBL] [Abstract][Full Text] [Related]
3. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
4. Fate of polyester arterial prostheses implanted as thoraco-abdominal by-passes in dogs: haematology, pathology, and biochemistry.
Merhi Y; Guidoin R; Forest JC
Clin Invest Med; 1988 Dec; 11(6):403-16. PubMed ID: 2976332
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
6. Prevention of thrombus formation on biomaterials exposed to blood using different antiplatelet drugs: experimental study in dogs.
Escudero MC; Alvarez L; de Haro J; Millán I; Jorge E; Castillo-Olivares JL
J Biomed Mater Res; 1994 Jan; 28(1):1-6. PubMed ID: 8126020
[TBL] [Abstract][Full Text] [Related]
7. The statistical analysis of distribution of blood deposits in arterial prostheses after short-term exposure to reduced blood flow in dogs: a computerized study using radioisotopes.
Bernier JM; Guidoin R; Bernier JP
Med Prog Technol; 1985; 10(4):183-99. PubMed ID: 4033596
[TBL] [Abstract][Full Text] [Related]
8. Early normalization of platelet survival by endothelial seeding of Dacron arterial prostheses in dogs.
Sharefkin JB; Latker C; Smith M; Cruess D; Clagett P; Rich NM
Surgery; 1982 Aug; 92(2):385-93. PubMed ID: 6213055
[TBL] [Abstract][Full Text] [Related]
9. Intimatan (dermatan 4,6-O-disulfate) prevents rethrombosis after successful thrombolysis in the canine model of deep vessel wall injury.
Hong TT; Van Gorp CL; Cardin AD; Lucchesi BR
Thromb Res; 2006; 117(3):333-42. PubMed ID: 15893368
[TBL] [Abstract][Full Text] [Related]
10. Severe thrombocytopenia delays but does not prevent the occlusion of an arterial prosthesis in rats.
Reyers I; Mussoni L; Donati MB; de Gaetano G
Thromb Haemost; 1981 Aug; 46(2):558-60. PubMed ID: 7053224
[TBL] [Abstract][Full Text] [Related]
11. A new microsurgical method for the induction of arterial thrombosis in rats.
van Aken PJ; Emeis JJ; Lindeman J
Artery; 1980; 8(5):442-7. PubMed ID: 7213051
[TBL] [Abstract][Full Text] [Related]
12. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
13. Prevention of experimental carotid artery thrombosis by applaggin.
Rote WE; Mu DX; Roncinske RA; Frelinger AL; Lucchesi BR
J Pharmacol Exp Ther; 1993 Nov; 267(2):809-14. PubMed ID: 8246155
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic modification of acute vascular graft thrombosis.
Hanson SR; Reidy MA; Hattori A; Harker LA
Scan Electron Microsc; 1982; (Pt 2):773-9. PubMed ID: 6762650
[TBL] [Abstract][Full Text] [Related]
15. Acute thrombogenicity of arterial prostheses exposed to reduced blood flow in dogs: effects of heparin, aspirin, and prostacyclin.
Merhi Y; Bernier J; Marois Y; Guidoin R
J Cardiovasc Pharmacol; 1995 Jul; 26(1):1-5. PubMed ID: 7564348
[TBL] [Abstract][Full Text] [Related]
16. [Thrombosis from prosthetic materials: prevention with different antiaggregatory agents. Low dose aspirin?].
Escudero MC; Alvarez L; Rodríguez V; de Haro J; Millán I; Torres MT; Jorge E; Castillo-Olivares JL
Rev Esp Cardiol; 1990; 43(6):385-91. PubMed ID: 2146720
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
Danese CA; Haimov M
Surgery; 1971 Dec; 70(6):927-34. PubMed ID: 5124672
[No Abstract] [Full Text] [Related]
18. Effects of external electrical stimulation on laser-beam-induced experimental thrombosis.
Aguejouf O; Doutremepuich F; Doutremepuich C
Pathophysiol Haemost Thromb; 2006; 35(5):364-9. PubMed ID: 17230037
[TBL] [Abstract][Full Text] [Related]
19. A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
Abendschein DR; Baum PK; Verhallen P; Eisenberg PR; Sullivan ME; Light DR
J Pharmacol Exp Ther; 2001 Feb; 296(2):567-72. PubMed ID: 11160645
[TBL] [Abstract][Full Text] [Related]
20. Effects of napsagatran (Ro 46-6240), a new synthetic thrombin inhibitor and of heparin in a canine model of coronary artery thrombosis: comparison with an ex vivo annular perfusion chamber model.
Roux S; Tschopp T; Baumgartner HR
J Pharmacol Exp Ther; 1996 Apr; 277(1):71-8. PubMed ID: 8613969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
